Hilary Weingarden1, Susanne S Hoeppner1, Ivar Snorrason1, Jennifer L Greenberg1, Katharine A Phillips2,3, Sabine Wilhelm1. 1. Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA. 2. New York-Presbyterian Hospital and Weill Cornell Medical College, New York City, New York, USA. 3. Rhode Island Hospital and Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Abstract
BACKGROUND: Little data exist on remission rates following psychotherapy for body dysmorphic disorder (BDD). METHODS: Using data from a large study of therapist-delivered cognitive behavior therapy (CBT) versus supportive psychotherapy (SPT) for BDD (N = 120), we estimated remission rates at treatment endpoint, and rates of delayed remission, sustained remission, and recurrence at 6-month follow-up. We also examined improvement in broader mental health outcomes among remitters. RESULTS: Full or partial remission rates at end-of-treatment were significantly higher following CBT (68%) than SPT (42%). At 6-month follow-up, an additional 10% (CBT) and 14% (SPT) experienced delayed remission, 52% (CBT) and 27% (SPT) experienced sustained remission, and 20% (CBT) and 14% (SPT) experienced recurrence. Remission was never achieved by 18% (CBT) and 45% (SPT). Participants in remission at end-of-treatment experienced significant improvements in functional impairment, depression severity, BDD-related insight, and quality of life compared to nonremitters. CONCLUSIONS: Full or partial remission rates are high following CBT for BDD and higher than after SPT.
BACKGROUND: Little data exist on remission rates following psychotherapy for body dysmorphic disorder (BDD). METHODS: Using data from a large study of therapist-delivered cognitive behavior therapy (CBT) versus supportive psychotherapy (SPT) for BDD (N = 120), we estimated remission rates at treatment endpoint, and rates of delayed remission, sustained remission, and recurrence at 6-month follow-up. We also examined improvement in broader mental health outcomes among remitters. RESULTS: Full or partial remission rates at end-of-treatment were significantly higher following CBT (68%) than SPT (42%). At 6-month follow-up, an additional 10% (CBT) and 14% (SPT) experienced delayed remission, 52% (CBT) and 27% (SPT) experienced sustained remission, and 20% (CBT) and 14% (SPT) experienced recurrence. Remission was never achieved by 18% (CBT) and 45% (SPT). Participants in remission at end-of-treatment experienced significant improvements in functional impairment, depression severity, BDD-related insight, and quality of life compared to nonremitters. CONCLUSIONS: Full or partial remission rates are high following CBT for BDD and higher than after SPT.
Authors: Katharine A Phillips; Aparna Keshaviah; Darin D Dougherty; Robert L Stout; William Menard; Sabine Wilhelm Journal: Am J Psychiatry Date: 2016-04-08 Impact factor: 18.112
Authors: Sabine Wilhelm; Hilary Weingarden; Jennifer L Greenberg; Thomas H McCoy; Ilana Ladis; Berta J Summers; Aleksandar Matic; Oliver Harrison Journal: Behav Ther Date: 2019-08-07
Authors: Georgina Krebs; Lorena Fernández de la Cruz; Benedetta Monzani; Laura Bowyer; Martin Anson; Jacinda Cadman; Isobel Heyman; Cynthia Turner; David Veale; David Mataix-Cols Journal: Behav Ther Date: 2017-01-10
Authors: Jennifer L Greenberg; Nicholas C Jacobson; Susanne S Hoeppner; Emily E Bernstein; Ivar Snorrason; Anna Schwartzberg; Gail Steketee; Katharine A Phillips; Sabine Wilhelm Journal: J Psychiatr Res Date: 2022-06-08 Impact factor: 5.250